VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ANIP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ANIPANI Pharmaceuticals, Inc.
$82.78$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksANIPQuarterly Cash Flow

ANI Pharmaceuticals, Inc. (ANIP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ANI Pharmaceuticals, Inc. (ANIP) quarterly cash flow statement — complete operating, investing & financing history

ANIP Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations58.38M30.37M44.05M75.81M34.99M15.86M12.47M17.41M18.27M44.74M32.17M20.63M21.42M-4.4M3.62M-11.48M-18.94M-12.19M-5.4M241K
Operating CF Margin %24.58%12.29%19.34%35.87%17.75%8.32%8.41%12.62%13.29%33.98%24.4%17.7%20.06%-4.67%4.32%-15.55%-29.38%-20%-10.38%0.5%
Operating CF Growth %66.83%91.47%253.17%335.35%91.53%-64.55%-61.22%-15.57%-14.73%1116.82%787.91%279.61%213.1%63.89%167.07%-4865.15%-191.65%-113.43%-234.7%-98.85%
Net Income27.43M27.49M26.62M8.55M15.68M-10.28M-24.17M-2.29M18.21M1.16M9.94M6.25M1.44M-4.24M-8.6M-14.92M-20.13M-24.14M-4.45M-14.11M
Depreciation & Amortization20.92M22.61M22.63M23.28M22.89M22.6M15.75M14.7M14.69M15.19M15.21M14.69M14.7M15.57M15.35M14.17M14.56M13.68M11.35M11.32M
Stock-Based Compensation09.77M9.69M9.6M8.87M7.06M7.48M7.86M6.93M5.62M5.44M5.25M4.34M3.74M3.87M3.76M3.24M2.97M2.81M2.84M
Deferred Taxes2.52M2.36M18.8M-3.54M-3.38M-17.53M-5.59M-1.9M3.1M-8.35M-3.26M-910K773K-1.63M-2.25M-3.91M-7.46M-8.09M-1.99M-6.4M
Other Non-Cash Items7.13M-5.01M-15.85M1.68M-10.39M18.79M10.67M3.54M-14.44M3.32M-731K2.08M1.95M2.92M4.62M-283K1.74M3.3M577K569K
Working Capital Changes382K-26.85M-17.84M36.24M1.33M-4.78M8.33M-4.5M-10.22M27.8M5.57M-6.73M-1.77M-20.76M-9.37M-10.29M-10.88M84K-13.7M6.01M
Change in Receivables25.53M-27.86M-26.96M-5.49M1.78M-25.51M8.44M6.33M-10.34M16.76M-5.92M1.79M-9.28M-25M9.98M-18.79M-3.1M5.37M-14.07M-772K
Change in Inventory-437K3.73M-8.16M-908K-625K-675K-6.36M-11.61M-2.64M-4.61M-2.27M-669K1.7M-9.46M-3.31M-9.39M-1.46M-5.55M5.95M1.95M
Change in Payables5.36M-7.24M13.77M3.08M5.55M-6.82M-3.08M-1.15M11.53M2.78M5.57M-3.9M3.1M10.06M-9.07M5.06M-1.01M9.77M-1.29M-774K
Cash from Investing-11.32M-1.4M-6.16M-6.91M-19.85M-10.68M-398.52M-4.45M8.93M-4.78M-4.55M-6.83M-2.35M-3.14M-9.81M-604K-2.18M-82.21M-583K-21.95M
Capital Expenditures-11.32M-9.38M-6.1M-4.01M-2.47M-2.39M-4.81M-4.45M-4.58M-2.28M-1.74M-2.5M-2.35M-3.14M-2.47M-1.32M-1.95M-368K-571K-932K
CapEx % of Revenue4.77%3.8%2.68%1.9%1.26%1.26%3.24%3.22%3.33%1.73%1.32%2.15%2.2%3.33%2.94%1.79%3.02%0.6%1.1%1.92%
Acquisitions00000-8.2M-393.08M0000000000-84.49M00
Investments--------------------
Other Investing07.98M-60K-2.9M-17.37M-86K-631K013.51M-2.5M-2.81M-4.33M-4K-4K-7.35M717K-229K2.65M-12K-21.02M
Cash from Financing-21.62M-4.64M6.34M-1.75M-9.91M-4.91M291.03M-1.45M-19.73M-11.92M3.75M80.15M-4.55M-508K-911K-1.44M-2.27M179.44M-3.02M20.9M
Debt Issued (Net)-4.06M-4.06M-2.03M-2.03M-2.03M36.57M-294.38M-750K-750K-750K-750K-750K-750K-750K-750K-750K-750K83.32M-2.83M21.17M
Equity Issued (Net)-17.55M-573K00-10M1.38M-680K-295K-8.66M-231K081.31M-3.55M-119K-239K-483K-1.12M96.32M-73K-468K
Dividends Paid00-344K-407K-406K-406K-406K-407K-406K-406K-406K-407K-406K-407K-406K-407K-405K-190K00
Share Repurchases-19.75M-611K00-10M-318K-680K-1.3M-8.66M-231K0-537K-3.55M-119K-239K-483K-1.12M-1K-73K-468K
Other Financing008.72M691K2.53M-42.45M586.49M0-9.91M-10.53M4.91M0157K768K484K203K3K0-121K195K
Net Change in Cash25.59M22.98M44.81M68M4.94M-123K-95.09M11.51M7.48M28.04M31.37M93.95M14.52M-8.05M-7.1M-13.53M-23.39M85.05M-9.01M-811K
Free Cash Flow52.3M6.51M37.89M68.9M15.14M13.38M7.66M12.96M13.69M39.96M27.62M13.8M19.07M-7.54M-6.19M-12.8M-21.12M-12.55M-5.99M-21.71M
FCF Margin %22.02%2.63%16.63%32.6%7.68%7.02%5.17%9.39%9.96%30.35%20.95%11.84%17.86%-8%-7.39%-17.34%-32.76%-20.6%-11.5%-44.65%
FCF Growth %245.34%-51.37%394.54%431.45%10.64%-66.52%-72.26%-6.05%-28.23%629.85%546.07%207.77%190.3%39.92%-3.44%41.02%-205.97%-60.36%19.37%-220.39%
FCF per Share2.430.311.803.390.760.690.390.670.702.081.440.771.15-0.46-0.38-0.79-1.31-0.88-0.49-1.80
FCF Conversion (FCF/Net Income)1.98x1.10x1.83x8.87x2.23x-1.54x-0.52x-7.61x1.00x38.74x3.24x3.30x14.89x1.04x-0.42x0.77x0.94x0.50x1.21x-0.02x
Interest Paid008.46M4.97M8.89M5.15M3.08M8.21M7.95M8.01M7.97M11.16M4.29M7.45M2.63M5.76M5.64M3.78M1.97M1.97M
Taxes Paid00140K16.19M285K1.85M016.35M852K298K789K-2.6M2.74M132K32K124K02.01M08.25M